Clinician follow-up of children screened for lead poisoning.

Por Markowitz, M, Rosen, J F, Clemente, I
Publicado em 1999

Intrauterine cocaine, lead, and nicotine exposure and fetal growth.

Por Neuspiel, D R, Markowitz, M, Drucker, E
Publicado em 1994

Children with moderately elevated blood lead levels: a role for other diagnostic tests?

Por Markowitz, M E, Clemente, I, Rosen, J F
Publicado em 1997

The expense of testing in a teaching hospital: the predominant role of high-cost tests.

Por Hartley, R M, Markowitz, M A, Komaroff, A L
Publicado em 1989

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection

Por Markowitz M, Wang Y, Streaker E, Xiao X, Chen W, Haynes B
Publicado em 2009-10-01

Relationships among blood lead levels, iron deficiency, and cognitive development in two-year-old children.

Por Ruff, H A, Markowitz, M E, Bijur, P E, Rosen, J F
Publicado em 1996

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection

Por Chen, W, Xiao, X, Streaker, E, Wang, Y, Markowitz, M, Haynes, B
Publicado em 2009

Hydrogen peroxide induced adenosine diphosphate ribosyl transferase (ADPRT) response in patients with inflammatory bowel disease.

Por Markowitz, M M, Rozen, P, Pero, R W, Tobi, M, Miller, D G
Publicado em 1988

Moderate lead poisoning: trends in blood lead levels in unchelated children.

Por Markowitz, M E, Bijur, P E, Ruff, H A, Balbi, K, Rosen, J F
Publicado em 1996

Use of Real-Time PCR and Molecular Beacons To Detect Virus Replication in Human Immunodeficiency Virus Type 1-Infected Individuals on Prolonged Effective Antiretroviral Therapy

Por Lewin, S. R., Vesanen, M., Kostrikis, L., Hurley, A., Duran, M., Zhang, L., Ho, D. D., Markowitz, M.
Publicado em 1999

Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor.

Por Markowitz, M, Mo, H, Kempf, D J, Norbeck, D W, Bhat, T N, Erickson, J W, Ho, D D
Publicado em 1995

Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.

Por Binley, J M, Klasse, P J, Cao, Y, Jones, I, Markowitz, M, Ho, D D, Moore, J P
Publicado em 1997

L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: public health implications.

Por Rosen, J F, Markowitz, M E, Bijur, P E, Jenks, S T, Wielopolski, L, Kalef-Ezra, J A, Slatkin, D N
Publicado em 1989

Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.

Por Rosen, J F, Markowitz, M E, Bijur, P E, Jenks, S T, Wielopolski, L, Kalef-Ezra, J A, Slatkin, D N
Publicado em 1991

Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.

Por Rosen, J F, Markowitz, M E, Bijur, P E, Jenks, S T, Wielopolski, L, Kalef-Ezra, J A, Slatkin, D N
Publicado em 1991

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease.

Por Patick, A K, Mo, H, Markowitz, M, Appelt, K, Wu, B, Musick, L, Kalish, V, Kaldor, S, Reich, S, Ho, D, Webber, S
Publicado em 1996

0A06-01. Multiplicity of infection by HIV-1 in injection drug users, men who have sex with men and heterosexuals

Por Bar, KJ, Li, H, Keele, B, Grayson, T, Sun, R, Chamberland, A, Tremblay, C, Markowitz, M, Schumacher, J, Hahn, B, Shaw, G
Publicado em 2009

Genotypic and Phenotypic Characterization of Human Immunodeficiency Virus Type 1 Variants Isolated from Patients Treated with the Protease Inhibitor Nelfinavir

Por Patick, A. K., Duran, M., Cao, Y., Shugarts, D., Keller, M. R., Mazabel, E., Knowles, M., Chapman, S., Kuritzkes, D. R., Markowitz, M.
Publicado em 1998

Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor.

Por Poppe, S M, Slade, D E, Chong, K T, Hinshaw, R R, Pagano, P J, Markowitz, M, Ho, D D, Mo, H, Gorman, R R, Dueweke, T J, Thaisrivongs, S, Tarpley, W G
Publicado em 1997

An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.

Por Jin, X., Ogg, G., Bonhoeffer, S., Safrit, J., Vesanen, M., Bauer, D., Chen, D., Cao, Y., Demoitie, M. A., Zhang, L., Markowitz, M., Nixon, D., McMichael, A., Ho, D. D.
Publicado em 2000